Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

August F Holtyn

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Preventive Medicine|March 11, 2014
The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trialAugust F Holtyn, Mikhail N Koffarnus, Anthony DeFulio, et al.
Drug and Alcohol Dependence|March 11, 2019
The effects of extended-release injectable naltrexone and incentives for opiate abstinence in heroin-dependent adults in a model therapeutic workplace: A randomized trialBrantley P Jarvis, August F Holtyn, Anthony DeFulio, et al.
Preventive Medicine|August 4, 2023
Abstinence-contingent wage supplements for adults experiencing homelessness and alcohol use disorder: A randomized clinical trialMatthew D Novak, Forrest Toegel, August F Holtyn, et al.
Addiction (Abingdon, England)|December 10, 2016
Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adultsBrantley P Jarvis, August F Holtyn, Anthony DeFulio, et al.
Addiction Science & Clinical Practice|November 18, 2024
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool-a protocol paperGerald T Cochran, Jennifer L Brown, Ziji Yu, et al.
AIDS and Behavior|July 13, 2019
Incentives for Viral Suppression in People Living with HIV: A Randomized Clinical TrialKenneth Silverman, August F Holtyn, Andrew M Rodewald, et al.
Frontiers in Psychiatry|July 12, 2021
An Examination of the Feasibility of Detecting Cocaine Use Using SmartwatchesEmre Ertin, Nithin Sugavanam, August F Holtyn, et al.
Behaviour Research and Therapy|April 7, 2022
Being at work improves stress, craving, and mood for people with opioid use disorder: Ecological momentary assessment during a randomized trial of experimental employment in a contingency-management-based therapeutic workplaceJeremiah W Bertz, Leigh V Panlilio, Samuel W Stull, et al.
Drug and Alcohol Dependence Reports|February 27, 2023
Quality of life during a randomized trial of a therapeutic-workplace intervention for opioid use disorder: Web-based mobile assessments reveal effects of drug abstinence and access to paid workJeremiah W Bertz, Kirsten E Smith, Leigh V Panlilio, et al.
BMJ Open|June 3, 2026
Emergency Department-initiated standard versus high-dose buprenorphine induction (ENVISION): a randomised clinical trial protocolKathryn Hawk, Andrew Herring, Marek Chawarski, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Preventive Medicine|March 11, 2014
The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trialAugust F Holtyn, Mikhail N Koffarnus, Anthony DeFulio, et al.
Drug and Alcohol Dependence|March 11, 2019
The effects of extended-release injectable naltrexone and incentives for opiate abstinence in heroin-dependent adults in a model therapeutic workplace: A randomized trialBrantley P Jarvis, August F Holtyn, Anthony DeFulio, et al.
Preventive Medicine|August 4, 2023
Abstinence-contingent wage supplements for adults experiencing homelessness and alcohol use disorder: A randomized clinical trialMatthew D Novak, Forrest Toegel, August F Holtyn, et al.
Addiction (Abingdon, England)|December 10, 2016
Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adultsBrantley P Jarvis, August F Holtyn, Anthony DeFulio, et al.
Addiction Science & Clinical Practice|November 18, 2024
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool-a protocol paperGerald T Cochran, Jennifer L Brown, Ziji Yu, et al.
AIDS and Behavior|July 13, 2019
Incentives for Viral Suppression in People Living with HIV: A Randomized Clinical TrialKenneth Silverman, August F Holtyn, Andrew M Rodewald, et al.
Frontiers in Psychiatry|July 12, 2021
An Examination of the Feasibility of Detecting Cocaine Use Using SmartwatchesEmre Ertin, Nithin Sugavanam, August F Holtyn, et al.
Behaviour Research and Therapy|April 7, 2022
Being at work improves stress, craving, and mood for people with opioid use disorder: Ecological momentary assessment during a randomized trial of experimental employment in a contingency-management-based therapeutic workplaceJeremiah W Bertz, Leigh V Panlilio, Samuel W Stull, et al.
Drug and Alcohol Dependence Reports|February 27, 2023
Quality of life during a randomized trial of a therapeutic-workplace intervention for opioid use disorder: Web-based mobile assessments reveal effects of drug abstinence and access to paid workJeremiah W Bertz, Kirsten E Smith, Leigh V Panlilio, et al.
BMJ Open|June 3, 2026
Emergency Department-initiated standard versus high-dose buprenorphine induction (ENVISION): a randomised clinical trial protocolKathryn Hawk, Andrew Herring, Marek Chawarski, et al.
Pageof 7